GE HealthCare to Acquire SOFIE Biosciences
- Posted on October 6, 2026
- By Google News
- 0 Views
- 1 min read
In brief
Generating AI summary…
GE HealthCare to Acquire SOFIE Biosciences
Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, at which time SOFIE Biosciences will become part of GE HealthCare’s PDx segment.